Hypermethylation and Post-Transcriptional Regulation of DNA Methyltransferases in the Ovarian Carcinomas of the Laying Hen

DNA methyltransferases (DNMTs) are key regulators of DNA methylation and have crucial roles in carcinogenesis, embryogenesis and epigenetic modification. In general, DNMT1 has enzymatic activity affecting maintenance of DNA methylation, whereas DNMT3A and DNMT3B are involved in de novo methylation events. Although DNMT genes are well known in mammals including humans and mice, they are not well studied in avian species, especially the laying hen which is recognized as an excellent animal model for research on human ovarian carcinogenesis. Results of the present study demonstrated that expression of DNMT1, DNMT3A and DNMT3B genes was significantly increased, particularly in the glandular epithelia (GE) of cancerous ovaries, but not normal ovaries. Consistent with this result, immunoreactive 5-methylcytosine protein was predominantly abundant in nuclei of stromal and GE cells of cancerous ovaries, but it was also found that, to a lesser extent, in nuclei of stromal cells of normal ovaries. Methylation-specific PCR analysis detected hypermethylation of the promoter regions of the tumor suppressor genes in the initiation and development of chicken ovarian cancer. Further, several microRNAs, specifically miR-1741, miR-16c, and miR-222, and miR-1632 were discovered to influence expression of DNMT3A and DNMT3B, respectively, via their 3′-UTR which suggests post-transcriptional regulation of their expression in laying hens. Collectively, results of the present study demonstrated increased expression of DNMT genes in cancerous ovaries of laying hens and post-transcriptional regulation of those genes by specific microRNAs, as well as control of hypermethylation of the promoters of tumor suppressor genes.

[1]  F. Bazer,et al.  Chicken Pleiotrophin: Regulation of Tissue Specific Expression by Estrogen in the Oviduct and Distinct Expression Pattern in the Ovarian Carcinomas , 2012, PloS one.

[2]  F. Bazer,et al.  Avian SERPINB11 gene: a marker for ovarian endometrioid cancer in chickens , 2012, Experimental biology and medicine.

[3]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[4]  S. Hua,et al.  DNA methyltransferases and methyl-binding proteins of mammals. , 2010, Acta biochimica et biophysica Sinica.

[5]  P. Laird Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[6]  Gary Goodman,et al.  Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study , 2010, Journal of the National Cancer Institute.

[7]  P. Bitterman,et al.  Histopathology of Ovarian Tumors in Laying Hens: A Preclinical Model of Human Ovarian Cancer , 2009, International Journal of Gynecologic Cancer.

[8]  S. Mok,et al.  Aberrant promoter methylation of SPARC in ovarian cancer. , 2009, Neoplasia.

[9]  Karen A. Johnson The Standard of Perfection: Thoughts about the Laying Hen Model of Ovarian Cancer , 2009, Cancer Prevention Research.

[10]  Elizabeth R. Smith,et al.  Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion. , 2008, The Lancet. Oncology.

[11]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[12]  P. Bitterman,et al.  Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. , 2008, Gynecologic oncology.

[13]  J. Ellinger,et al.  Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. , 2008, The Journal of urology.

[14]  M. Esteller Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[15]  C. Croce,et al.  MicroRNA expression and function in cancer. , 2006, Trends in molecular medicine.

[16]  Hui-Juan Yang,et al.  Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data , 2006, BMC Cancer.

[17]  T. Spencer,et al.  Progesterone and interferon-tau regulate cystatin C in the endometrium. , 2006, Endocrinology.

[18]  K. Schuebel,et al.  De novo CpG island methylation in human cancer cells. , 2006, Cancer research.

[19]  E. OscarTapia,et al.  Estudio del patrón de metilación génico en el cáncer gástrico en Chile , 2005 .

[20]  Jean-François Ethier,et al.  Reproductive Biology and Endocrinology Open Access Animal Models of Ovarian Cancer , 2022 .

[21]  K. Stakleff,et al.  Rodent models for ovarian cancer research , 2003, International Journal of Gynecologic Cancer.

[22]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[23]  K. Robertson DNA methylation and chromatin – unraveling the tangled web , 2002, Oncogene.

[24]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  Peter A. Jones,et al.  The Role of DNA Methylation in Mammalian Epigenetics , 2001, Science.

[27]  W. Grizzle,et al.  Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. , 2001, Gynecologic oncology.

[28]  J. D. den Dunnen,et al.  The PWWP domain: a potential protein–protein interaction domain in nuclear proteins influencing differentiation? , 2000, FEBS letters.

[29]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[30]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[31]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.

[32]  Y. Uchijima,et al.  Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1. , 2008, Developmental biology.

[33]  P. Mozdziak,et al.  CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. , 2007, Gynecologic oncology.

[34]  J. Araya,et al.  [Promoter methylation profile in gastric cancer]. , 2005, Revista medica de Chile.

[35]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[36]  Fathalla Mf Incessant ovulation--a factor in ovarian neoplasia? [letter] , 1971 .